Barany 1998

Methods	Study design: RCT Study duration: NS
Participants	Setting: NS Country: Sweden Stage of CKD: HD Number: epoetin beta (39), no treatment (37) Mean age ± SD (years): overall 23 to 78 years Sex (M/F): 49/27 Other characteristics: stable Hb levels between 9.0 and 12.0 g/dL at baseline Exclusion criteria: NS
Interventions	Treatment group Epoetin beta Titrated to maintain Hb level of 9.0 to 12.0 g/dL for 3 to 4 months Control group Standard care Iron supplementation NS
Outcomes	Exercise tolerance
Notes	Abstract‐only publication